Hyper-activation of RANKL signaling results in enhanced osteoclast formation and bone resorption, which is common in the pathologic bone destruction, including rheumatoid arthritis, bone tumor and bone metastasis, periodontitis. This evidence concerns the gene TNFSF11 and bone neoplasm.